(Q36895509)

16 August 2017

1 reference

title

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future (English)

1 reference

16 August 2017

0 references

Anna Wieckowska

1

1 reference

16 August 2017

Arthur J McCullough

series ordinal

2

1 reference

16 August 2017

Ariel E Feldstein

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

16 August 2017

1 reference

16 August 2017

46

1 reference

16 August 2017

582-589

1 reference

16 August 2017

2

1 reference

Nonalcoholic fatty liver disease

16 August 2017

1 reference

7 January 2021

Prevalence of fatty liver in children and adolescents.

1 reference

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

7 January 2021

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

7 January 2021

Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups

1 reference

7 January 2021

Test validity of periodic liver function tests in a population of Japanese male bank employees

1 reference

7 January 2021

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

7 January 2021

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

1 reference

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

7 January 2021

One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation

1 reference

7 January 2021

The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients

1 reference

7 January 2021

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

7 January 2021

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

1 reference

7 January 2021

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis

1 reference

7 January 2021

Blood oxidative stress markers are unreliable markers of hepatic steatosis

1 reference

7 January 2021

Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations

1 reference

7 January 2021

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

7 January 2021

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

1 reference

7 January 2021

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

1 reference

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

7 January 2021

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis

1 reference

7 January 2021

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

7 January 2021

High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

1 reference

7 January 2021

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

7 January 2021

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

1 reference

7 January 2021

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

1 reference

7 January 2021

Steatohepatitis and apoptosis: therapeutic implications

1 reference

7 January 2021

Apoptosis in alcoholic and nonalcoholic steatohepatitis

1 reference

7 January 2021

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

7 January 2021

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

1 reference

7 January 2021

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

7 January 2021

Noninvasive measures of liver fibrosis

1 reference

7 January 2021

Liver fibrosis in overweight patients

1 reference

7 January 2021

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

7 January 2021

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

7 January 2021

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

7 January 2021

Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.

1 reference

7 January 2021

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

7 January 2021

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

1 reference

7 January 2021

Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease

1 reference

7 January 2021

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21768

1 reference

16 August 2017

1 reference